IGF2BP2 and neoplasm: It has been reported that forms of IGF2BP2 exosomes migrate to endothelial cells, promote angiogenesis in LUAD, cause tumor invasion and poor prognosis, and IGF2BP2 knockdown inhibits tumor metastasis and angiogenesis [198].